Abu Shaigah, F., Zabbani, A., Qadi, A., Aloufi, A., Sultan, A., Aljuwayd, H., Ghawas, A., Alawadh, A., Alam, F., Alghamdi, M., Alenzi, R., Jish, F. (2017). Impact of Dysphagia Therapy in Parkinson’s Disease. The Egyptian Journal of Hospital Medicine, 69(4), 2258-2265. doi: 10.12816/0041527
Faisal Ahmed M. Abu Shaigah; Ahlammohammed Zabbani; Alya Bakr A. Qadi; Abdulrahman Mohammed M Aloufi; Anmar Ahmed T Sultan; Hussain Abdullah Aljuwayd; Ahmed Ali H Ghawas; Ahmed Mohammed Alawadh; Fayezaemadaldeen Alam; Mohammed Abdullah Alghamdi; Reem Salem M Alenzi; Fatimah Nader Al Jish. "Impact of Dysphagia Therapy in Parkinson’s Disease". The Egyptian Journal of Hospital Medicine, 69, 4, 2017, 2258-2265. doi: 10.12816/0041527
Abu Shaigah, F., Zabbani, A., Qadi, A., Aloufi, A., Sultan, A., Aljuwayd, H., Ghawas, A., Alawadh, A., Alam, F., Alghamdi, M., Alenzi, R., Jish, F. (2017). 'Impact of Dysphagia Therapy in Parkinson’s Disease', The Egyptian Journal of Hospital Medicine, 69(4), pp. 2258-2265. doi: 10.12816/0041527
Abu Shaigah, F., Zabbani, A., Qadi, A., Aloufi, A., Sultan, A., Aljuwayd, H., Ghawas, A., Alawadh, A., Alam, F., Alghamdi, M., Alenzi, R., Jish, F. Impact of Dysphagia Therapy in Parkinson’s Disease. The Egyptian Journal of Hospital Medicine, 2017; 69(4): 2258-2265. doi: 10.12816/0041527
Impact of Dysphagia Therapy in Parkinson’s Disease
Background: Dysphagia is a common symptom in Parkinson's disease (PD) which indicates a difficulty in swallowing. It has been accompanied with poor quality of life (QoL), anxiety and depression. Aim of the Study: to assess the effects of dysphagia treatment in Parkinson’s disease. Materials and methods: Studies published up to July 2017 were found via a systematic comprehensive electronic database search using PubMed, Embase, and The Cochrane Library.Two reviewers independently assessed the studies using strict inclusion criteria. Results: Thirteen studies were enrolled in the present study and qualitatively analyzed using critical appraisal items. The review includes rehabilitative (exercises, electrical stimulation, bolus modification etc.) and pharmacologic treatment. Some well-designed controlled trials were included. However, none of the included studies fulfilled all criteria for external and internal validity. Thus, a meta-analysis was not carried out as most of the studies were not of sufficient quality. Conclusion: Rehabilitative treatment including Expiratory Muscle Strength Training (EMST) may be effective for dysphagia treatment solely coupled with dopaminergic therapy for PD. Recently developed other treatment methods such as implant-prosthodontic treatment and percutaneous injection of botulinum neurotoxin type A in the cricopharyngeal muscle on dysphagia is rather promising. Nevertheless, these preliminary results warrant further investigation concerning their clinical applicability, and further research should be conducted.
View on SCiNiTO
Top